ANDA 83897, held by Solvay. Butabarbital Sodium.
As of Nov 16, 2026, ANDA 83897 (Butabarbital Sodium), held by Solvay, was first approved by FDA on Jun 21, 1974, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 21, 1974 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Butabarbital Sodium48.6MG ยท tablet;oral | Butabarbital Sodium | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters